Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

China flag China · Delayed Price · Currency is CNY
18.62
+0.24 (1.31%)
Mar 10, 2026, 2:04 PM CST
0.54%
Market Cap 4.03B
Revenue (ttm) 351.25M
Net Income (ttm) 7.10M
Shares Out 219.47M
EPS (ttm) 0.03
PE Ratio 568.40
Forward PE n/a
Dividend 1.20 (6.49%)
Ex-Dividend Date Jun 12, 2025
Volume 1,403,208
Average Volume 1,805,236
Open 18.09
Previous Close 18.38
Day's Range 18.09 - 18.67
52-Week Range 16.10 - 23.28
Beta 0.31
RSI 43.29
Earnings Date Apr 24, 2026

About SHE:002932

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents and diagnostic instruments in China. The company offers external diagnostic testing, third-party medical testing, certification consulting services, and medical information platform construction services. It also provides information software and supporting hardware products. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. was founded in 2008 and is based in Wuhan, China. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2008
Employees 812
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002932
Full Company Profile

Financial Performance

In 2024, SHE:002932's revenue was 350.06 million, a decrease of -53.30% compared to the previous year's 749.54 million. Earnings were 74.52 million, a decrease of -0.54%.

Financial Statements

News

There is no news available yet.